However, by the finish of that time, the Dutch team found simply no improvement in the participants’ mental functioning, if they stopped the medications or not. The researchers said there are a number of possible explanations why halting high blood pressure treatment had no influence on brain function, including the known truth that none of the participants had serious cardiovascular disease. Dr. Luca Giliberto is an investigator at the Litwin-Zucker Research Center for the Study of Alzheimer’s Disease, area of the Feinstein Institute for Medical Analysis in Manhasset, N.Y.The results, published in Individual Molecular Genetics, represent a paradigm shift for the treatment of muscular dystrophy in addition to a host of additional disabling and devastating muscles diseases. The study was led by Mahasweta Girgenrath, PhD, assistant professor and director of the Muscle tissue Disorders and Regenerative Biology Laboratory at BU Sargent College's Section of Health Sciences. Boston University researchers and postdoctoral fellows Jenny Yamauchi, Ajay Kumar, Lina Duarte, and Thomas Mehuron were collaborators on this scholarly study.